ÌÇÐÄÊÓÆµ

Noah Freeman Shroyer

Shroyer

Noah Freeman Shroyer, Ph.D.

Associate Professor

(713) 798-8693

Positions

Associate Professor
Department of Medicine Section of Gastroenterology and Hepatology
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas
Adjunct Associate Professor
Department of Pediatrics Division of Gastroenterology, Hepatology & Nutrition Cincinnati Children's Hospital
University of Cincinnati
Cincinnati, Ohio
Member
Dan L Duncan Comprehensive Cancer Center
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Core Director
Digestive Diseases Center
Texas Medical Center
/research/centers/digestive-disease

Addresses

BCM-Alkek Graduate School (Lab)
Room: BCMN-N1301
Houston, TX, 77030
United States

Education

BS from Louisiana State University
Baton Rouge, Louisiana, United States
Microbiology and Biochemistry
PhD from ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Cell and Molecular Biology
Post-Doctoral Fellowship at ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Molecular and Human Genetics

Professional Interests

  • Mechanisms that control intestinal development and homeostasis
  • Human Enteroids

Professional Statement

My laboratory is focused on understanding the mechanisms that control intestinal development and homeostasis, and translating this knowledge into novel therapeutic approaches to treat diseases of the intestine such as IBD and colorectal cancer. My laboratory has elucidated roles for epithelial transcription factors such as Atoh1 (Math1), Gfi1, and Spdef in development and differentiation of the intestine. Moreover, my laboratory has translated these findings to human diseases, by showing that Atoh1 and its target Spdef are tumor suppressors that are frequently silenced in colon cancers, and that these genes are essential targets of Notch inhibitory drugs. In addition to these mechanistic studies, we have recently developed novel organ culture methods to direct differentiation of human pluripotent stem cells into intestinal tissue to study intestinal development and disease, and we have used intestinal stem cell-derived organoids in quantitative assays to evaluate intestinal stem cell activity.

Websites

Selected Publications

  • Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn AM, Shroyer NF, Wells JM.. " " 2011 Feb ;
    Pubmed PMID: .
  • Noah TK, Shroyer NF.. " " 2013 ;
    Pubmed PMID: .
  • Lo Y-H., Chung, E., Li, Z., Wan, Y-W., Mahe, M.M., Chen, M-S., Noah, T.K., Bell, K.N., Yalamanchili, H.K., Klisch, T.J., Liu, Z., Park, J-S., Shroyer, N.F.. " " Cellular and Molecular Gastroenterology and Hepatology.. 2017 ; 3 : 51-71.
    Pubmed PMID: .
  • Lo Y-H., Noah, T.K., Chen, M-S., Zou, W., Borras, E., Vilar, E., Shroyer, N.F.. " " Gastroenterology. 2017 ; 153 : 205-218.
    Pubmed PMID: .

to edit your profile